Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Location
Tennessee
Nashville
A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
Apply
Bemarituzumab
A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step